Authors:
Propato, A
Schiaffella, E
Vicenzi, E
Francavilla, V
Baloni, L
Paroli, M
Finocchi, L
Tanigaki, N
Ghezzi, S
Ferrara, R
Chesnut, R
Livingston, B
Sette, A
Paganelli, R
Aiuti, F
Poli, G
Barnaba, V
Citation: A. Propato et al., Spreading of HIV-specific CD8(+) T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity, HUMAN IMMUN, 62(6), 2001, pp. 561-576
Authors:
Altfeld, MA
Livingston, B
Reshamwala, N
Nguyen, PT
Addo, MM
Shea, A
Newman, M
Fikes, J
Sidney, J
Wentworth, P
Chesnut, R
Eldridge, RL
Rosenberg, ES
Robbins, GK
Brander, C
Sax, PE
Boswell, S
Flynn, T
Buchbinder, S
Goulder, PJR
Walker, BD
Sette, A
Kalams, SA
Citation: Ma. Altfeld et al., Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif, J VIROLOGY, 75(3), 2001, pp. 1301-1311
Authors:
Heathcote, J
McHutchison, J
Lee, S
Tong, M
Benner, K
Minuk, G
Wright, T
Fikes, J
Livingston, B
Sette, A
Chestnut, R
Citation: J. Heathcote et al., A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus, HEPATOLOGY, 30(2), 1999, pp. 531-536
Authors:
Ishioka, GY
Fikes, J
Hermanson, G
Livingston, B
Crimi, C
Qin, MS
del Guercio, MF
Oseroff, C
Dahlberg, C
Alexander, J
Chesnut, RW
Sette, A
Citation: Gy. Ishioka et al., Utilization of MHC class I transgenic mice for development of minigene DNAvaccines encoding multiple HLA-restricted CTL epitopes, J IMMUNOL, 162(7), 1999, pp. 3915-3925